Fidelity Biopharma Drug Patent Portfolio
Fidelity Biopharma owns 1 orange book drug protected by 2 US patents Given below is the list of Fidelity Biopharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12042484 | Tizanidine liquid preparation and use thereof | 07 May, 2042 | Active |
| US12263158 | Tizanidine liquid preparation and use thereof | 07 May, 2042 | Active |
Fidelity Biopharma's Family Patents
Fidelity Biopharma Drug List
Given below is the complete list of Fidelity Biopharma's drugs and the patents protecting them.
1. Ontralfy
Ontralfy is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12042484 | Tizanidine liquid preparation and use thereof |
07 May, 2042
(16 years from now)
| Active |
| US12263158 | Tizanidine liquid preparation and use thereof |
07 May, 2042
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ontralfy's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List